Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.71 |
| ▸ | CES1 | P23141 | 2/20 | 0.59 |
| ▸ | BCHE | P06276 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | HPN | P05981 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | PDE4A | P27815 | 1/20 | 0.50 |
| ▸ | KDR | P35968 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30008537 | 0.91 | MAOA (0.59) | MAOACES1BCHEALDH1A1MEN1 | |
| SCHEMBL3271360 | 0.88 | MAOA (0.61) | MAOACES1BCHEALDH1A1MEN1 | |
| SCHEMBL30185448 | 0.84 | MAOA (0.61) | MAOACES1BCHEALDH1A1MEN1 | |
| SCHEMBL29522447 | 0.84 | MAOA (0.61) | MAOACES1BCHEALDH1A1MEN1 | |
| SCHEMBL30177232 | 0.84 | MAOA (0.61) | MAOACES1BCHEALDH1A1MEN1 | |
| SCHEMBL1204733 | 0.84 | MAPT (0.75) | MAOACES1BCHEALDH1A1MEN1 | |
| SCHEMBL4652610 | 0.84 | MAOA (0.61) | MAOACES1BCHEALDH1A1MEN1 | |
| SCHEMBL10782961 | 0.84 | MAOA (0.61) | MAOACES1BCHEALDH1A1MEN1 | |
| SCHEMBL29364462 | 0.84 | MAOA (0.61) | MAOACES1BCHEALDH1A1MEN1 | |
| SCHEMBL17796874 | 0.84 | MAOA (0.61) | MAOACES1BCHEALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 282 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600673-B2 | Composite member, and heat generation device, building member and light emitting device, each of which uses same | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2026-04-14 | — | — | US | claimed |
| US-20260018687-A1 | SEPARATOR, SECONDARY BATTERY INCLUDING SEPARATOR, AND POWER CONSUMING APPARATUS | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2026-01-15 | — | — | US | claimed |
| EP-3943085-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2022-01-26 | — | — | EP | claimed |
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH ZURICH (CH) | 2021-06-24 | — | — | US | claimed |
| EP-3801507-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2021-04-14 | — | — | EP | claimed |
| EP-3201675-B1 | ELECTROWETTING DISPLAY DEVICE COMPRISING A RADIATION FILTER | AMAZON TECH INC (US) | 2020-11-04 | — | — | EP | claimed |
| US-10312546-B2 | Non-aqueous liquid electrolyte for secondary battery and secondary battery | FUJIFILM CORPORATION (JP) | 2019-06-04 | — | — | US | claimed |
| US-9964870-B2 | Electrophotographic photoreceptor and image forming apparatus and image forming method using the same | Konica Minolta, Inc. (JP) | 2018-05-08 | — | — | US | claimed |
| EP-3201675-A1 | ELECTROWETTING DISPLAY DEVICE COMPRISING A RADIATION FILTER | Amazon Technologies Inc. (US) | 2017-08-09 | — | — | EP | claimed |
| US-20160091709-A1 | ELECTROWETTING DISPLAY DEVICE | AMAZON TECHNOLOGIES, INC. | 2016-03-31 | — | — | US | claimed |
| WO-2004113464-A1 | THERMALLY ACTIVATABLE REMOVABLE ADHESIVE TAPES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2004-12-29 | — | — | WO | claimed |
| US-20030007250-A1 | Temperature compensation of Bragg reflection gratings | FORCETEC CO., LTD. (KR) | 2003-01-09 | — | — | US | claimed |
| EP-0932131-B1 | Optical smoke detector | SIEMENS BUILDING TECH AG (CH) | 2003-01-02 | — | — | EP | claimed |
| US-6063849-A | CONTAINING PHOTOSENSISTIZER IN PHOTOELECTRIC CONTACT WITH ZINC OXIDE; FISH NETS, WATER CONDUITS, BOAT HULLS, SHOWER CURTAINS, BATHROOM FIXTURES, HOSPITAL WALLS | CAPE COD RESEARCH, INC. (US) | 2000-05-16 | — | — | US | claimed |
| US-5916947-A | WHICH HAS BEEN SURFACE COATED BY PHOTOSENSITIZER(S) WHICH INCREASE THE CAPABILITY OF ZINC OXIDE TO ABSORB VISIBLE LIGHT. | CAPE COD RESEARCH, INC. (US) | 1999-06-29 | — | — | US | claimed |
| US-5663029-A | DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| US-5639413-A | THREE-DIMENSIONAL OBJETS; USING AN EPOXY-FUNCTIONAL SILICON CONTAINING MONOMER | CRIVELLO JAMES VINCENT (US) | 1997-06-17 | — | — | US | claimed |
| WO-1996030182-A1 | METHODS AND COMPOSITIONS RELATED TO STEREOLITHOGRAPHY | CRIVELLO JAMES V (US) | 1996-10-03 | — | — | WO | claimed |
| WO-1996017007-A1 | ZINC OXIDE PHOTOACTIVE MATERIAL | CAPE COD RESEARCH, INC. (US) | 1996-06-06 | — | — | WO | claimed |
| US-4455741-A | Fabrication of solid state electronic devices using fluorescent imaging of surface temperature profiles | AT&T BELL LABORATORIES (US) | 1984-06-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260018687-A1 | SEPARATOR, SECONDARY BATTERY INCLUDING SEPARATOR, AND POWER CONSUMING APPARATUS | CTCF, EBP, AS3MT | MAOA 1015/4885CES1 983/4885BCHE 207/4885 |
| US-12600673-B2 | Composite member, and heat generation device, building member and light emitting device, each of which uses same | ILK, PIEZO1, TRPA1 | MAOA 488/4885CES1 4650/4885BCHE 4207/4885 |
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | TOMM70, TOMM34, TIMM50 | MAOA 3628/4885CES1 1693/4885BCHE 3474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.